Reckitt Benckiser Group (OTCMKTS:RBGLY) Lifted to Strong-Buy at Barclays

Barclays upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLY) to a strong-buy rating in a research report sent to investors on Friday morning, Zacks.com reports.

Several other equities research analysts have also weighed in on RBGLY. JPMorgan Chase & Co. lowered Reckitt Benckiser Group from an overweight rating to a neutral rating in a report on Thursday, August 29th. Citigroup upgraded shares of Reckitt Benckiser Group to a strong-buy rating in a research note on Tuesday, October 1st. Finally, UBS Group raised shares of Reckitt Benckiser Group to a strong-buy rating in a research report on Wednesday, September 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, one has given a buy rating and three have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of Moderate Buy.

Reckitt Benckiser Group Price Performance

Reckitt Benckiser Group stock opened at $11.93 on Friday. Reckitt Benckiser Group has a one year low of $10.24 and a one year high of $15.03. The company’s fifty day moving average price is $11.56 and its two-hundred day moving average price is $11.30.

Reckitt Benckiser Group Cuts Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 23rd. Shareholders of record on Monday, August 5th were issued a dividend of $0.1915 per share. The ex-dividend date was Monday, August 5th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.